Detalhe da pesquisa
1.
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma.
Nature
; 594(7863): 418-423, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33953400
2.
Topology Optimized Prelithiated SiO Anode Materials for Lithium-Ion Batteries.
Small
; 18(27): e2202209, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35686333
3.
Ancient volcanos as species pumps: A case study of freshwater amphipods in Northeast Asia.
Mol Ecol
; 31(1): 343-355, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34657344
4.
Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative-Intent Surgery and/or Ablation for Metastatic Rectal Cancer.
Ann Surg Oncol
; 2022 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35377061
5.
Prediction of epithelial-to-mesenchymal transition molecular subtype using CT in gastric cancer.
Eur Radiol
; 32(1): 1-11, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120231
6.
First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanoma.
J Am Acad Dermatol
; 87(5): 989-996, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36068115
7.
A phase 1 dose-escalation and dose-expansion study to assess the safety and efficacy of CKD-516, a novel vascular disrupting agent, in combination with Irinotecan in patients with previously treated metastatic colorectal cancer.
Invest New Drugs
; 39(5): 1335-1347, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33829355
8.
Programmed Death Ligand 1 Expression as a Prognostic Marker in Patients with Advanced Biliary Tract Cancer.
Oncology
; 99(6): 365-372, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33730723
9.
Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors.
Gastric Cancer
; 24(2): 457-466, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32970267
10.
A Deep Learning Approach with Data Augmentation to Predict Novel Spider Neurotoxic Peptides.
Int J Mol Sci
; 22(22)2021 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830173
11.
A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor-Induced Skin Toxicities.
Oncologist
; 25(1): e186-e193, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31492766
12.
FGFR2-Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape.
Oncologist
; 24(11): 1462-1468, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31249137
13.
Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial.
Oncology
; 97(1): 38-43, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31048579
14.
Comprehensive molecular and clinical characterization of Asian melanoma patients treated with anti-PD-1 antibody.
BMC Cancer
; 19(1): 805, 2019 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31412814
15.
Asymmetric Synthesis of Enantioenriched 2-Aryl-2,3-Dihydrobenzofurans by a Lewis Acid Catalyzed Cyclopropanation/Intramolecular Rearrangement Sequence.
Angew Chem Int Ed Engl
; 58(38): 13427-13432, 2019 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31309680
16.
Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors.
Oncologist
; 23(2): 155-e17, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29158363
17.
Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line.
BMC Cancer
; 18(1): 1103, 2018 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30419860
18.
Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single-Blind, Crossover Phase III Trial.
Oncologist
; 22(11): 1354-1361, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28687626
19.
Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients and Utility for Biomarker-Selected Clinical Trials.
Oncologist
; 22(10): 1169-1177, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28701572
20.
Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy.
BMC Cancer
; 17(1): 211, 2017 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28330462